Giovanni Tallini

ORCID: 0000-0003-0113-6682 · 7 papers in corpus · active 2021-2026

Study types

  • article 4
  • other 2
  • review 1

Condition tags

  • endometriosis 7
article 2026
1039 Molecular and Immunophenotypic Alterations in Endometriosis: Markers of Early Neoplastic Evolution
·doi:10.1016/j.labinv.2025.105329
article 2025
1061 From Endometriosis to Ovarian Carcinoma: Revealing Molecular Changes in Neoplastic Progression Through NGS Panel Analysis
·doi:10.1016/j.labinv.2024.103295
article 2025
Endometriosis-Associated Ovarian Carcinomas: Histotypes and Molecular Profiling
article 2025
From Endometriosis to Ovarian Cancer: Revealing Molecular Changes in Neoplastic Progressionthrough NGS Panel Analysis
other 2025
MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer
Translational oncology ·doi:10.1016/j.tranon.2025.102367

BACKGROUND: Endometriosis (EMS) is a chronic, gynecological condition affecting 6-10 % of reproductive-age women. While these lesions are benign, ovarian EMS presents cancer-like features, and can progress to endometriosis-correlated ovaria…

other 2025
MiRNome alterations drive the malignant transformation of endometriosis into endometriosis-correlated ovarian cancer
Scientific reports ·doi:10.1038/s41598-025-26466-3

Endometriosis (EMS) is a chronic gynecological condition affecting 6-10% of reproductive-age women. These lesions, albeit of benign nature, present cancer-like features, and may progress to epithelial ovarian cancer (EOC) through a multiste…

review 2021
What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors
Diagnostics ·doi:10.3390/diagnostics11040697

Ovarian carcinomas represent a heterogeneous group of neoplasms consisting of separate entities with distinct risk factors, precursor lesions, pathogenesis, patterns of spread, molecular profiles, clinical course, response to chemotherapy, …